REPORT ID 2018

EMEA (Europe, Middle East and Africa) Insulin Market Report 2017

Publish Date
7-Dec-17
Pages
102
Format
Electronic (PDF)

In this report, the EMEA Insulin market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Doses), revenue (Million USD), market share and growth rate of Insulin for these regions, from 2012 to 2022 (forecast)
    Europe: Germany, France, UK, Russia, Italy and Benelux;
    Middle East: Saudi Arabia, Israel, UAE and Iran;
    Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Insulin market competition by top manufacturers/players, with Insulin sales volume (K Doses), price (USD/Dose), revenue (Million USD) and market share for each manufacturer/player; the top players including
    Novo Nordisk
    Sanofi
    Eli Lilly
    Bioton
    Dongbao
    Gan & Lee
    United Laboratories (TUL)
    ...

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
    Short-acting
    Mid-acting
    Long-acting

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Hospital
    Clinic
    Home Usage

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

EMEA (Europe, Middle East and Africa) Insulin Market Report 2017
1 Insulin Overview
    1.1 Product Overview and Scope of Insulin
    1.2 Classification of Insulin
        1.2.1 EMEA Insulin Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 EMEA Insulin Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Short-acting
        1.2.4 Mid-acting
        1.2.5 Long-acting
    1.3 EMEA Insulin Market by Application/End Users
        1.3.1 EMEA Insulin Sales (Volume) and Market Share Comparison by Application (2012-2022
        1.3.2 Hospital
        1.3.3 Clinic
        1.3.4 Home Usage
    1.4 EMEA Insulin Market by Region
        1.4.1 EMEA Insulin Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 Europe Status and Prospect (2012-2022)
        1.4.3 Middle East Status and Prospect (2012-2022)
        1.4.4 Africa Status and Prospect (2012-2022)
    1.5 EMEA Market Size (Value and Volume) of Insulin (2012-2022)
        1.5.1 EMEA Insulin Sales and Growth Rate (2012-2022)
        1.5.2 EMEA Insulin Revenue and Growth Rate (2012-2022)

2 EMEA Insulin Competition by Manufacturers/Players/Suppliers, Region, Type and Application
    2.1 EMEA Insulin Market Competition by Players/Manufacturers
        2.1.1 EMEA Insulin Sales Volume and Market Share of Major Players (2012-2017)
        2.1.2 EMEA Insulin Revenue and Share by Players (2012-2017)
        2.1.3 EMEA Insulin Sale Price by Players (2012-2017)
    2.2 EMEA Insulin (Volume and Value) by Type/Product Category
        2.2.1 EMEA Insulin Sales and Market Share by Type (2012-2017)
        2.2.2 EMEA Insulin Revenue and Market Share by Type (2012-2017)
        2.2.3 EMEA Insulin Sale Price by Type (2012-2017)
    2.3 EMEA Insulin (Volume) by Application
    2.4 EMEA Insulin (Volume and Value) by Region
        2.4.1 EMEA Insulin Sales and Market Share by Region (2012-2017)
        2.4.2 EMEA Insulin Revenue and Market Share by Region (2012-2017)
        2.4.3 EMEA Insulin Sales Price by Region (2012-2017)

3 Europe Insulin (Volume, Value and Sales Price), by Players, Countries, Type and Application
    3.1 Europe Insulin Sales and Value (2012-2017)
        3.1.1 Europe Insulin Sales Volume and Growth Rate (2012-2017)
        3.1.2 Europe Insulin Revenue and Growth Rate (2012-2017)
    3.2 Europe Insulin Sales and Market Share by Type
    3.3 Europe Insulin Sales and Market Share by Application
    3.4 Europe Insulin Sales Volume and Value (Revenue) by Countries
        3.4.1 Europe Insulin Sales Volume by Countries (2012-2017)
        3.4.2 Europe Insulin Revenue by Countries (2012-2017)
        3.4.3 Germany Insulin Sales and Growth Rate (2012-2017)
        3.4.4 France Insulin Sales and Growth Rate (2012-2017)
        3.4.5 UK Insulin Sales and Growth Rate (2012-2017)
        3.4.6 Russia Insulin Sales and Growth Rate (2012-2017)
        3.4.7 Italy Insulin Sales and Growth Rate (2012-2017)
        3.4.8 Benelux Insulin Sales and Growth Rate (2012-2017)

4 Middle East Insulin (Volume, Value and Sales Price), by Region, Type and Application
    4.1 Middle East Insulin Sales and Value (2012-2017)
        4.1.1 Middle East Insulin Sales Volume and Growth Rate (2012-2017)
        4.1.2 Middle East Insulin Revenue and Growth Rate (2012-2017)
    4.2 Middle East Insulin Sales and Market Share by Type
    4.3 Middle East Insulin Sales and Market Share by Application
    4.4 Middle East Insulin Sales Volume and Value (Revenue) by Countries
        4.4.1 Middle East Insulin Sales Volume by Countries (2012-2017)
        4.4.2 Middle East Insulin Revenue by Countries (2012-2017)
        4.4.3 Saudi Arabia Insulin Sales and Growth Rate (2012-2017)
        4.4.4 Israel Insulin Sales and Growth Rate (2012-2017)
        4.4.5 UAE Insulin Sales and Growth Rate (2012-2017)
        4.4.6 Iran Insulin Sales and Growth Rate (2012-2017)

5 Africa Insulin (Volume, Value and Sales Price) by Players, Countries, Type and Application
    5.1 Africa Insulin Sales and Value (2012-2017)
        5.1.1 Africa Insulin Sales Volume and Growth Rate (2012-2017)
        5.1.2 Africa Insulin Revenue and Growth Rate (2012-2017)
    5.2 Africa Insulin Sales and Market Share by Type
    5.3 Africa Insulin Sales and Market Share by Application
    5.4 Africa Insulin Sales Volume and Value (Revenue) by Countries
        5.4.1 Africa Insulin Sales Volume by Countries (2012-2017)
        5.4.2 Africa Insulin Revenue by Countries (2012-2017)
        5.4.3 South Africa Insulin Sales and Growth Rate (2012-2017)
        5.4.4 Nigeria Insulin Sales and Growth Rate (2012-2017)
        5.4.5 Egypt Insulin Sales and Growth Rate (2012-2017)
        5.4.6 Algeria Insulin Sales and Growth Rate (2012-2017)

6 EMEA Insulin Manufacturers/Players Profiles and Sales Data
    6.1 Novo Nordisk
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Insulin Product Type, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Novo Nordisk Insulin Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Sanofi
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Insulin Product Type, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Sanofi Insulin Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Eli Lilly
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Insulin Product Type, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Eli Lilly Insulin Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Bioton
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Insulin Product Type, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Bioton Insulin Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Dongbao
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Insulin Product Type, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Dongbao Insulin Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Gan & Lee
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Insulin Product Type, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Gan & Lee Insulin Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 United Laboratories (TUL)
        6.7.1 Company Basic Information, Manufacturing Base and Competitors
        6.7.2 Insulin Product Type, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 United Laboratories (TUL) Insulin Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    ...

7 Insulin Manufacturing Cost Analysis
    7.1 Insulin Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Insulin

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Insulin Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Insulin Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 EMEA Insulin Market Forecast (2017-2022)
    11.1 EMEA Insulin Sales, Revenue and Price Forecast (2017-2022)
        11.1.1 EMEA Insulin Sales and Growth Rate Forecast (2017-2022)
        11.1.2 EMEA Insulin Revenue and Growth Rate Forecast (2017-2022)
        11.1.3 EMEA Insulin Price and Trend Forecast (2017-2022)
    11.2 EMEA Insulin Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.3 Europe Insulin Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.4 Middle Eastt Insulin Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.5 Africa Insulin Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.6 EMEA Insulin Sales Forecast by Type (2017-2022)
    11.7 EMEA Insulin Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer